![]() |
|
|
Vol. 286, Issue 2, 903-912, August 1998
Unit of Pharmacology, Department of Pharmacobiology, Faculty of
Pharmacy, University of Bari, Bari, Italy
This study was aimed at investigating the effects of chronic treatment
of aged rats with growth hormone (GH, 8 weeks) or the GH-secretagogue
hexarelin (4 weeks) on the biophysical modifications that voltage-gated
sodium channels of skeletal muscle undergo during aging, by means of
the patch-clamp technique applied to fast-twitch muscle fibers. Two
phenotypes of aged-rat fibers could be discriminated on the basis of
channel conductance. In the young phenotype, sodium channels present a
conductance of 18 pS as in young-adult rats. In the aged phenotype,
channels present a conductance of 9 pS while ensemble average currents
activate and inactivate more slowly. Nevertheless, in all situations,
sodium channels shared a number of biophysical properties, such as open
probability, mean open time, steady-state inactivation and
use-dependent inhibition. Furthermore, channel density on
extrajunctional sarcolemma was higher in aged rats, a result
independent of the phenotype. Chronic treatment of aged rats with
either GH or hexarelin restored current kinetics but not channel
conductance and density. These results confirm the specific age-related
changes in sodium channel behavior and show that treatment with either
GH or hexarelin has partial restorative effects. Moreover, hexarelin
restored the firing capacity of fast-twitch muscle fibers, as did GH in
previous studies. These findings support the possible therapeutic value
of the synthetic peptide in cases of GH deficiency, as in the elderly.
This article has been cited by other articles:
![]() |
Z.-M. Wang, Z. Zheng, M. L. Messi, and O. Delbono Extension and magnitude of denervation in skeletal muscle from ageing mice J. Physiol., June 15, 2005; 565(3): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Desaphy, S. Pierno, A. De Luca, P. Didonna, and D. C. Camerino Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders Mol. Pharmacol., March 1, 2003; 63(3): 659 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Desaphy, S. Pierno, C. Leoty, A. L. George Jr, A. De Luca, and D. C. Camerino Skeletal muscle disuse induces fibre type-dependent enhancement of Na+ channel expression Brain, June 1, 2001; 124(6): 1100 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tivesten, E. Bollano, K. Caidahl, V. Kujacic, X. Y. Sun, T. Hedner, A. Hjalmarson, B.-A. Bengtsson, and J. Isgaard The Growth Hormone Secretagogue Hexarelin Improves Cardiac Function in Rats after Experimental Myocardial Infarction Endocrinology, January 1, 2000; 141(1): 60 - 66. [Abstract] [Full Text] [PDF] |
||||